WeGene
PrivateLast Round
Series C
Jan 26, 2022
Company Overview
WeGene operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series C round in January 2022.
WeGene is a biotechnology company that provides personal genetic testing, genomic data analysis, and personalized healthcare services with a focus on East Asian populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics
Business Model
B2C
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WeGene Comparables
Compare WeGene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genebox | 93% | |
| 23Mofang | 92% | |
| Mega Genomics | 82% |
For institutional investors. Book with your work email.
WeGene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 26, 2022 | ||||
| Strategic | Jul 5, 2018 | ||||
| Series B | Jan 29, 2018 | ||||
| Series A | Sep 1, 2015 | ||||
| Angel | Aug 17, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
WeGene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ameba Capital | Series B |
| 险峰K2VC | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 78% MoM, reaching 57K.
- Jan 5, 2026
Monthly visitors increased 35% MoM.
For institutional investors. Book with your work email.
WeGene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about WeGene's valuation, stock price, and market status.
Is WeGene a public or private company?
WeGene is a private company.
What is the current stock price of WeGene?
WeGene is a private company, so its shares have no public market price. Caplight tracks WeGene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is WeGene worth (valuation)?
Valuation information for WeGene is not publicly available.
Can I buy WeGene stock?
WeGene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was WeGene's last funding round?
WeGene's most recent funding round was Series C on January 26, 2022.
Who are the main investors in WeGene?
Key investors in WeGene include Ameba Capital, 险峰K2VC.
Will WeGene IPO soon?
No public IPO plans have been announced for WeGene.
How can I track WeGene secondary market activity?
Caplight tracks bids, offers, and trades in WeGene's shares on secondary markets.